Global Melatonin Market to Reach USD 5.67 Billion by 2031 | CAGR 20.5% According to a newly published market research report by 24LifeSciences, global melatonin market was valued at USD 1.59 billion in 2024 and is projected to reach USD 5.67 billion by 2031, growing at a compound annual growth rate (CAGR) of 20.5% during the forecast period 2025–2031. Melatonin, clinically known as N-acetyl-5-methoxytryptamine, is a naturally occurring hormone primarily secreted by the pineal gland that plays a critical role in regulating circadian rhythms and the sleep-wake cycle. Beyond its primary function in sleep regulation, it is also recognized for its potent antioxidant properties and potential benefits in immune modulation and neuroprotection. Its status as an over-the-counter dietary supplement in many regions has made it widely accessible for managing insomnia, jet lag, and shift work sleep disorder. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/6664/melatonin-market-market

Risk Factors and Medications Linked to Sleep Bruxism Pain Sleep bruxism pain is influenced by stress, anxiety, sleep disorders, and lifestyle habits such as caffeine or alcohol use. Certain medications, including antidepressants and stimulants, may increase muscle activity during sleep. Identifying triggers, managing stress, adjusting medications under supervision, and using protective appliances help reduce discomfort and prevent dental damage. visit https://gohardsdental.com/sleep-bruxism-risks-medications-tmj-pain-factors/